Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-05 11:20 am Purchase | 2026-06-30 | 13G | SUMMIT HOTEL PPTYS INC INN | UBS Group AG | 8,757,861 8.100% | 8,757,861 (New Position) | Filing History |
| 2026-08-05 10:54 am Purchase | 2026-06-30 | 13G | IHS HLDG LTD IHS | UBS Group AG | 19,394,037 5.800% | 19,394,037 (New Position) | Filing History |
| 2026-08-04 5:32 pm Purchase | 2026-06-30 | 13G | RISING DRAGON ACQ CORP ORFD SH RDAC | UBS Group AG | 324,628 5.500% | 324,628 (New Position) | Filing History |
| 2026-08-04 5:05 pm Purchase | 2026-06-30 | 13G | STARLINK AI ACQUISITION CORP U OTAIU | UBS Group AG | 740,668 5.400% | 740,668 (New Position) | Filing History |
| 2026-08-03 4:28 pm Sale | 2026-06-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 480,458 30.000% | -50,910 (-9.58%) | Filing History |
| 2026-08-03 11:40 am Purchase | 2026-06-30 | 13G | NUVEEN CALIF MUN VALUE FUND NCA | UBS Group AG | 2,170,465 6.600% | 377,470 (+21.05%) | Filing History |
| 2026-07-31 4:46 pm Sale | 2026-06-30 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | UBS Group AG | 0 0.000% | -746,095 (Position Closed) | Filing History |
| 2026-07-31 4:19 pm Unchanged | 2026-06-30 | 13G | AMC ENTMT HLDGS INC AMC | UBS Group AG | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-07-31 3:27 pm Sale | 2025-12-31 | 13G | AMC ENTMT HLDGS INC AMC | UBS Group AG | 0 0.000% | -31,798,761 (Position Closed) | Filing History |
| 2026-05-07 4:17 pm Purchase | 2026-03-31 | 13G | VIPSHOP HLDGS LTD SPONSORED AD VIPS | UBS Group AG | 16,129,947 20.000% | 186,677 (+1.17%) | Filing History |
| 2026-05-07 4:06 pm Sale | 2026-03-31 | 13G | WESTERN ASSET INVESTMENT GRADE IGI | UBS Group AG | 0 0.000% | -345,414 (Position Closed) | Filing History |
| 2026-05-07 12:56 pm Purchase | 2026-03-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | UBS Group AG | 746,095 5.800% | 746,095 (New Position) | Filing History |
| 2026-05-07 11:56 am Purchase | 2026-03-31 | 13G | APEX TECH ACQUISITION INC USD TRADU | UBS Group AG | 762,688 5.400% | 762,688 (New Position) | Filing History |
| 2026-05-07 11:28 am Purchase | 2026-03-31 | 13G | AMICUS THERAPEUTICS INC FOLD | UBS Group AG | 17,141,817 5.500% | 17,141,817 (New Position) | Filing History |
| 2026-05-01 09:41 am Sale | 2026-03-31 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 531,368 33.200% | -26,878 (-4.81%) | Filing History |
| 2026-01-30 2:09 pm Purchase | 2025-12-31 | 13G | NUVEEN CALIF MUN VALUE FUND NCA | UBS Group AG | 1,792,995 5.400% | 1,792,995 (New Position) | Filing History |
| 2026-01-30 2:00 pm Purchase | 2025-12-31 | 13G | AMC ENTMT HLDGS INC AMC | UBS Group AG | 31,798,761 6.200% | 31,798,761 (New Position) | Filing History |
| 2026-01-07 10:30 am Sale | 2025-12-31 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 558,246 34.900% | -91,605 (-14.10%) | Filing History |
| 2025-10-24 1:05 pm Sale | 2025-09-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 649,851 40.600% | -33,006 (-4.83%) | Filing History |
| 2025-07-29 1:39 pm Sale | 2025-06-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 682,857 42.700% | -25,911 (-3.66%) | Filing History |